Clinical Trials Browser

Phase 1/2 × Mesothelioma × Bevacizumab × Clear all

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT00604461 2017-03-23

Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)

Phase 1/2 Terminated

13 enrolled 7 charts

Other solid neoplasmThoracic

Mesothelioma

Clinical Trials

RAINFOL-01

Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)